Two Daily Disposable Contact Lenses in Symptomatic Patients
Completed · Not applicable
Conditions studied: Myopia
In brief
The purpose of this study is to evaluate the performance of DAILIES TOTAL1® and ACUVUE OASYS® 1-DAY and with respect to visual acuity in a symptomatic study population of monthly or bi-weekly replacement lens wearers.
Key facts
- Study ID
- NCT03628599
- Run by
- Alcon Research
- People needed
- 39
- Starts
- 2018-08-13
- Expected to finish
- 2018-09-25
- Last updated by the study team
- 2019-07-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Able to understand and must sign an IRB-approved informed consent form;
- Soft contact lens wearers in both eyes during the past 3 months;
- Best-corrected visual acuity (BCVA) 20/25 or better in each eye;
- Willing to wear study lenses at least 3 days per week and at least 8 hours per day;
- Willing to stop wearing habitual contact lenses for the duration of study participation.
You may not qualify if…
- Infection, inflammation, abnormality, condition, disease, surgery, or use of medications, as specified in the protocol;
- Intolerance, hypersensitivity, or allergy to any component of the study products;
- Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
- Monocular (only one eye with functional vision).
Where it is running
- Alcon Investigative Site — Bloomington, Illinois, United States
- Alcon Investigative Site — Pittsburg, Kansas, United States
- Alcon Investigative Site — Powell, Ohio, United States
- Alcon Investigative Site — Warwick, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.